Filing Details
- Accession Number:
- 0000899243-22-031032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-14 16:05:19
- Reporting Period:
- 2022-09-12
- Accepted Time:
- 2022-09-14 16:05:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 749660 | Icad Inc | ICAD | Surgical & Medical Instruments & Apparatus (3841) | 020377419 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380206 | Jonathan Go | C/O Icad Inc 98 Spit Brook Road Suite 100 Nashua NH 03062 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-12 | 45,000 | $2.27 | 227,685 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-12 | 37,880 | $2.74 | 189,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-12 | 1,080 | $2.65 | 188,725 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-09-12 | 45,000 | $0.00 | 45,000 | $2.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-09-25 | 2022-09-25 | No | 4 | M | Direct |
Footnotes
- Represents sales made pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, intended to cover the exercise price of options that expire on September 25, 2022.
- The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.86 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on September 12, 2022.
Billionaire Hedge Funds
